Clinical Trial Update: Vaccination With GSK 1024850A in Children Primed With GSK 1024850A & Boosted With Pneumovax 23™ [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating vaccination with GSK 1024850A in children primed with GSK 1024850A and boosted with Pneumovax 23, with completed status and re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Streptococcal Infections
• Streptococcus Pneumoniae Infections

Drugs mentioned

• GSK 1024850A
• Pneumovax 23 (Pneumococcal polysaccharide vaccine 23-valent)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Streptococcal, Streptococcus Pneumoniae | Phase 3 | Status: COMPLETED | Results posted: 2017-01-06